BONE GLA PROTEIN AND SEX HORMONE-BINDING GLOBULIN IN NONTOXIC GOITER - PARAMETERS FOR METABOLIC STATUS AT THE TISSUE-LEVEL

被引:46
作者
FABER, J
PERRILD, H
JOHANSEN, JS
机构
[1] FREDERIKSBERG UNIV HOSP, DEPT ENDOCRINOL E, DK-2000 COPENHAGEN, DENMARK
[2] GLOSTRUP CTY HOSP, DEPT CLIN CHEM, DK-2600 GLOSTRUP, DENMARK
关键词
D O I
10.1210/jcem-70-1-49
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several patients with nontoxic goiter have reduced serum TSH levels, as measured with new sensitive assays. Whether this is a sign of subclinical hyperthyroidism, thus having the potential of adverse effects on different organs with time, is not known. We have measured serum levels of 2 markers of thyrometabolic status at the tissue level, bone γ-carboxyglutamic acidcontaining protein (BGP), reflecting the function of osteoblasts, and sex hormone-binding globulin (SHBG), reflecting the function of hepatocytes, in 44 patients (41 women and 3 men) with nontoxic goiter (11 diffuse and 33 nodular goiters; serum T4, T3, free T4, and free T3levels had been normal and stable for at least 0.5 yr). Serum TSH levels ranged from normal to unmeasurably low values (<0.05 mU/L). Serum TSH levels correlated negatively to serum BGP levels (r = -0.60; P < 0.001). Due to the postmenopausal surge in serum BGP levels, premenopausal women (n = 21) were tested separately without changing the significance (r = -0.53; P < 0.02). Expressing serum BGP values as a percentage of the mean value in control subjects of the same age and sex did not change the correlation (r = -0.63; P < 0.001). Six patients had serum BGP levels above the normal range, and patients with reduced serum TSH levels (<0.45 mU/L; n = 12) had significantly enhanced serum BGP levels [median, 1.53 nmol/L (range, 1.02–4.24) vs. 1.23 nmol/L (0.62–3.71); P < 0.05]. Serum TSH also correlated negatively to serum SHBG levels (r = -0.56; P < 0.001; women alone: r = -0.58; P < 0.001). Eight patients had serum SHBG levels above the normal range, and patients with reduced serum TSH levels had significantly enhanced serum SHBG levels, expressed as a percentage of the mean control value for the relevant sex [203% (range, 75–288) vs. 120% (42–317); P < 0.01]. It is concluded that the lower serum TSH levels in patients with nontoxic goiter, the higher are serum BGP and SHBG levels. This suggests a progressively generalized (not only pituitary) tissue overexposure to thyroid hormones, the lower the serum TSH levels. Therefore, the finding of a reduced serum TSH level in patients with nontoxic goiter might reflect supraphysiological levels of T4and/or T3, which could possibly be harmful. © 1990 by The Endocrine Society.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 25 条
[1]   SEX-HORMONE-BINDING GLOBULIN [J].
ANDERSON, DC .
CLINICAL ENDOCRINOLOGY, 1974, 3 (01) :69-96
[2]   FACTORS AFFECTING SUPPRESSION OF ENDOGENOUS THYROTROPIN SECRETION BY THYROXINE TREATMENT - RETROSPECTIVE ANALYSIS IN ATHYREOTIC AND GOITROUS PATIENTS [J].
BARTALENA, L ;
MARTINO, E ;
PACCHIAROTTI, A ;
GRASSO, L ;
AGHINILOMBARDI, F ;
BURATTI, L ;
BAMBINI, G ;
BRECCIA, M ;
PINCHERA, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (04) :849-855
[3]   RAISED PLASMA GLUTATHIONE S-TRANSFERASE VALUES IN HYPERTHYROIDISM AND IN HYPOTHYROID PATIENTS RECEIVING THYROXINE REPLACEMENT - EVIDENCE FOR HEPATIC DAMAGE [J].
BECKETT, GJ ;
KELLETT, HA ;
GOW, SM ;
HUSSEY, AJ ;
HAYES, JD ;
TOFT, AD .
BRITISH MEDICAL JOURNAL, 1985, 291 (6493) :427-431
[4]   RELATIONSHIPS BETWEEN SERUM THYROTROPIN, SERUM FREE THYROXINE-(T4), AND 3,5,3'-TRIIODOTHYRONINE-(T3) AND THE DAILY T4-PRODUCTION AND T3-PRODUCTION RATES IN EUTHYROID PATIENTS WITH MULTINODULAR GOITER [J].
BREGENGARD, C ;
KIRKEGAARD, C ;
FABER, J ;
POULSEN, S ;
HASSELSTROM, K ;
SIERSBAEKNIELSEN, K ;
FRIIS, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (02) :258-261
[5]  
BROWN JP, 1984, LANCET, V1, P1091
[6]   FINE ADJUSTMENT OF THYROXINE REPLACEMENT DOSAGE - COMPARISON OF THE THYROTROPIN RELEASING HORMONE TEST USING A SENSITIVE THYROTROPIN ASSAY WITH MEASUREMENT OF FREE THYROID-HORMONES AND CLINICAL-ASSESSMENT [J].
CARR, D ;
MCLEOD, DT ;
PARRY, G ;
THORNES, HM .
CLINICAL ENDOCRINOLOGY, 1988, 28 (03) :325-333
[7]   ESTIMATION OF BONE TURNOVER EVALUATED BY CA-47 KINETICS - EFFICIENCY OF SERUM BONE GAMMA-CARBOXYGLUTAMIC ACID-CONTAINING PROTEIN, SERUM ALKALINE-PHOSPHATASE, AND URINARY HYDROXYPROLINE EXCRETION [J].
CHARLES, P ;
POSER, JW ;
MOSEKILDE, L ;
JENSEN, FT .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (06) :2254-2258
[8]  
COINDRE JM, 1986, ARCH INTERN MED, V146, P48, DOI 10.1001/archinte.146.1.48
[9]   SERUM BONE GLA-PROTEIN COMPARED TO BONE HISTOMORPHOMETRY IN ENDOCRINE DISEASES [J].
DELMAS, PD ;
MALAVAL, L ;
ARLOT, ME ;
MEUNIER, PJ .
BONE, 1985, 6 (05) :339-341
[10]   SERUM FREE T4, T3, RT3, 3,3'-DIIODOTHYRONINE AND 3',5'-DIIODOTHYRONINE MEASURED BY ULTRAFILTRATION [J].
FABER, J ;
ROGOWSKI, P ;
KIRKEGAARD, C ;
SIERSBAEKNIELSEN, K ;
FRIIS, T .
ACTA ENDOCRINOLOGICA, 1984, 107 (03) :357-365